G01N 2800/44
Multiple drug resistance
G01N2800/44 (Multiple drug resistance) appears on 93 US grants and 157 published applications in this corpus.
Search patents in G01N- Granted patents
- 93
- Published applications
- 157
- Assignees
- 111
- Inventors
- 313
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 1 |
| 2003 | 3 | 2 |
| 2004 | 0 | 7 |
| 2005 | 1 | 3 |
| 2006 | 1 | 5 |
| 2007 | 1 | 8 |
| 2008 | 2 | 5 |
| 2009 | 5 | 10 |
| 2010 | 5 | 19 |
| 2011 | 4 | 8 |
| 2012 | 7 | 6 |
| 2013 | 7 | 13 |
| 2014 | 1 | 10 |
| 2015 | 3 | 8 |
| 2016 | 6 | 6 |
| 2017 | 2 | 4 |
| 2018 | 5 | 5 |
| 2019 | 3 | 5 |
| 2020 | 3 | 6 |
| 2021 | 2 | 5 |
| 2022 | 5 | 9 |
| 2023 | 2 | 3 |
| 2024 | 2 | 7 |
| 2025 | 5 | 1 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for diagnosis or treatment of anticancer drug resistance25 Aug 2026US 12,716,888 B2
- Compositions, methods, and systems for detecting methicillin-resistant Staphylococcus aureus26 May 2026US 12,638,447 B2Laboratory Corporation of America Holdings
- Preparing live microbial samples and microorganisms for subsequent mass spectrometric measurement and evaluation31 Mar 2026US 12,590,971 B2
- Mass spectrometric measurement of β-lactamase resistances7 Oct 2025US 12,435,352 B2Bruker Daltonics, Inc.
- Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections20 May 2025US 12,303,562 B2Rutgers, The State University of New Jersey
- Antimicrobial peptides30 Oct 2025US 2025/0332215 A1Provincial Health Services Authority
- Preparing live microbial samples and microorganisms for subsequent mass spectrometric measurement and evaluation26 Sep 2024US 2024/0319204 A1Bruker Daltonics, Inc.
- Anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections19 Sep 2024US 2024/0307535 A1Rutgers, The State University of New Jersey
- Methods of using usp15 inhibitors25 Jul 2024US 2024/0245664 A1The Curators of the University of Missouri
- Combination therapies targeting mitochondrial biogenesis for cancer therapy27 Jun 2024US 2024/0207202 A1The Wistar Institute of Anatomy and Biology
Most cited
By later US patents
- Method of using multicellular particulates to analyze malignant or hyperproliferative tissue82US 6,416,967 B2Precision Therapeutics, Inc. · 2002
- Method of reversing carboplatin resistance by inhibition of HGFIN25US 8,383,806 B2University of Medicine and Dentistry of New Jersey · 2013
- Methods for cancer prognosis and diagnosis19US 6,511,806 B1Oncotech, Inc. · 2003
- Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use18US 9,527,905 B2MedImmune, LLC · 2016
- Genes and genetic elements associated with sensitivity to chemotherapeutic drugs15US 5,665,550 ABoard of Trustees of the University of Illinois-Urbana · 1997